Proton pump inhibitor‐induced large gastric polyps can regress within 2 months after discontinuation: Experience from two cases

Documenti analoghi

• Endoscopic features of gastric neuroendocrine tumors
  di: Katsunori Matsueda, et al.
  Pubblicazione: (2025)
• Endoscopic findings and outcomes of gastric mucosal changes relating to potassium‐competitive acid blocker and proton pump inhibitor therapy
  di: Satoshi Shinozaki, et al.
  Pubblicazione: (2024)
• Combination of artificial intelligence endoscopic diagnosis and Kimura‐Takemoto classification determined by endoscopic experts may effectively evaluate the stratification of gastric atrophy in post‐eradication status
  di: Kumiko Kirita, et al.
  Pubblicazione: (2024)
• Profound gastric mucosal changes and severe rebound acid hypersecretion after long‐term Vonoprazan use: A case report
  di: Hiroko Suda, et al.
  Pubblicazione: (2024)
• Visibility Evaluation of Fundic Gland Polyp Associated With Proton Pump Inhibitor in Texture and Color Enhancement Imaging
  di: Ryota Uchida, et al.
  Pubblicazione: (2025)